Aldeyra The (ALDX)

NASDAQ
Currency in USD
3.350
+0.265(+8.59%)
Closed·
After Hours
3.380+0.030(+0.896%)
·
ALDX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ALDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.0003.370
52 wk Range
1.1407.200
Key Statistics
Edit
Prev. Close
3.085
Open
3.079
Day's Range
3-3.37
52 wk Range
1.14-7.2
Volume
685.23K
Average Volume (3m)
1.83M
1-Year Change
1.82%
Book Value / Share
1.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALDX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.667
Upside
+158.71%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period

Aldeyra The News & Analysis

Show more

Aldeyra The Company Profile

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platform, including ADX 248, ADX 743, ADX 631, ADX 246, and other product candidates in development for inflammatory and metabolic diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Compare ALDX to Peers and Sector

Metrics to compare
ALDX
Peers
Sector
Relationship
P/E Ratio
−3.5x−4.6x−0.5x
PEG Ratio
0.040.020.00
Price/Book
3.2x2.6x2.6x
Price / LTM Sales
-1,523.8x3.0x
Upside (Analyst Target)
202.5%212.4%50.5%
Fair Value Upside
Unlock6.2%7.5%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.667
(+158.71% Upside)

Earnings

Latest Release
May 01, 2025
EPS / Forecast
-0.17 / -0.2865
Revenue / Forecast
-- / -1,330,000.00
EPS Revisions
Last 90 days

People Also Watch

0.270
NUWE
-8.79%
15.720
CRMD
-5.07%
33.40
CYTK
+2.33%
1.34
MGNX
+1.52%
6.940
UNCY
-2.39%

FAQ

What Is the Aldeyra The (ALDX) Share Price Today?

The live Aldeyra The share price today is 3.35.

What Stock Exchange Does Aldeyra The (ALDX) Trade On?

Aldeyra The is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Ticker (Stock Symbol) for Aldeyra The?

The stock symbol (also called a 'ticker') for Aldeyra The is "ALDX."

What Is the Current Aldeyra The Market Cap?

As of today, Aldeyra The market capitalisation is 200.65M.

What Is Aldeyra The's (ALDX) Earnings Per Share (TTM)?

The Aldeyra The EPS -0.97 (Trailing Twelve Months).

When Is the Next Aldeyra The Earnings Date?

Aldeyra The's next earnings report will be released on 07 Aug 2025.

Is ALDX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Aldeyra The moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Aldeyra The Stock Split?

Aldeyra The has split 0 times. (See the ALDX stock split history page for full effective split date and price information.)

How Many Employees Does Aldeyra The Have?

Aldeyra The currently has 8 employees.

What is the current trading status of Aldeyra The (ALDX)?

As of 25 Jun 2025, Aldeyra The (ALDX) is trading at a price of 3.35, with a previous close of 3.09. The stock has fluctuated within a day range of 3.00 to 3.37, while its 52-week range spans from 1.14 to 7.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.